The Johnson & Johnson Vaccine Pause Explained

For years, a debate has been simmering in Silicon Valley over the right way to build artificial intelligence. Should it be open and free for anyone to use, or should we tightly control how it’s made and who can access it? Mike Isaac, who covers technology for The New York Times, ...  Show more

This summer, wildfires have been raging across Europe. France and Spain have been hit particularly badly, with hundreds of thousands of acres incinerated and entire communities devastated. Chico Harlan, the global climate correspondent for The New York Times, and Mark Landler, th ...  Show more

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

The Centers for Disease Control and Prevention and the Food and Drug Administration announced a recommended pause in use of Johnson & Johnson's single-use COVID-19 vaccine, while the agencies investigate reports of a rare but serious blood clot in six people. The pause comes at a ...  Show more

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more

CNN’s Chief Medical Correspondent Dr. Sanjay Gupta walks through what we currently know about the CDC and FDA's decision to pause the use of Johnson & Johnson's Covid-19 vaccine, what this means for people who recently received a J&J shot, and why he isn’t panicking. To learn mor ...  Show more